Family Medicine News Alerts
- Alert FDA OKs Triclabendazole for Tropical Disease Fascioliasis
- Alert EU Panel Recommends Fenspiride Suspension Because of Heart Risks
- Alert FDA Panels Endorse Ketamine Spray for Resistant Depression
- Alert FDA Cracks Down on Illegal Sale of Alzheimer's 'Cures'
- Alert FDA OKs First Targeted Therapy for Rare Blood Clotting Disorder
- Alert Trump Tackles Drug Costs, HIV, Abortion in State of the Union
- Alert ACIP Releases 2019 Child and Teen Vaccine Schedule
- Alert Abuse-Deterrent OxyContin Tied to Spike in Hepatitis C
- Alert EU Panel Recommends Humira Biosimilars Idacio, Kromeya
- Alert FDA Approves First Generic of Advair Diskus
- Alert Intensive BP Lowering Cuts MCI Risk: Results Published
- Alert FDA Clears First Diagnostic Test for Mycoplasma genitalium
- Alert FDA Moves to Fast-Track OTC Naloxone for Opioid Overdose
- Alert FDA Clears First Generic Version of Seizure Drug Sabril
- Alert FDA Clears Epilepsy Smartwatch for Use in Children
- Alert Sanofi's Pediatric Hexavalent Vaccine Approved by U.S. FDA
- Alert FDA Clears Test to Analyze Nutrients in Breast Milk
- Alert U.S. FDA Approves New Protocol for Study on Bayer's Essure Birth Control Device
- Alert FDA Warns Genetech Over Unapproved Stem-Cell Products
- Alert FDA OKs Prucalopride (Motegrity) for Chronic Idiopathic Constipation